Kisspeptin-10 vs Enclomiphene: What the Research Shows
Kisspeptin-10 and Enclomiphene side by side: what they are, how they are regulated and what is still unknown.
Where the research points
Consider Kisspeptin-10 if…
- you want human hormone data (infusion in men; a hormone-level outcome): At 4 ug/kg/h for 22.5 h, LH rose from 5.4 to 20.8 IU/liter and testosterone from 16.6 to 24.0 nmol/liter.[17]
- you want to see the dosing limitation in women: responses fell with repeated dosing: LH and FSH responses fell sharply by day 14 of twice-daily injections (LH +2.5 IU/liter, FSH +0.5 IU/liter).[18]
Consider Enclomiphene if…
- you want an oral option with randomized testosterone data against a gel: At 25 mg daily, day-42 testosterone averaged 604 ng/dL versus 500 ng for transdermal testosterone.[9]
- you want randomized data on sperm concentration versus testosterone gel: Sperm concentration stayed in the normal range with enclomiphene but fell markedly with testosterone gel.[8]
What they have in common
Spec comparison
Showing 9 of 11 fields where the two differ. PCAC vote, Jul 2026, Evidence strength are the same or both unknown.
| Field | Kisspeptin-10 | Enclomiphene |
|---|---|---|
| Class | GnRH stimulator | SERM (not a peptide) |
| Also called | kiss | enclo |
| Category | Sexual & hormonal health | Other |
| FDA status | Not FDA approved · research chemical | Not FDA approved · compounded |
| PCAC vote, Jul 2026 | Not on the Jul 2026 agenda | Not on the Jul 2026 agenda |
| WADA | Prohibited by WADA (S2.2.1)Kisspeptin and its agonist analogues are named in S2.2.1 (testosterone-stimulating peptides in males). | Prohibited by WADA (S4.2)Enclomiphene is an isomer of clomifene, which is named in S4.2 (anti-estrogens/SERMs, prohibited at all times). Enclomiphene itself is not spelled out in the list text we cached, so this rests on it being a form of clomifene. |
| Anti-doping detection |
|
|
| Half-life | mean elimination half-life 1.3-2.2 hourssubcutaneous (analog MVT-602) · Fertility and sterility 2024, PMID 37925096 | No published half-life foundPubMed search, 11 Oct 2026 |
| Evidence strength | Human RCT evidence, 4 of 4Strongest: European journal of endocrinology 2026, PMID 42549827 | Human RCT evidence, 4 of 4Strongest: BJU international 2016, PMID 26496621 |
| Human studies we summarised | 14 human (10 randomized or controlled) of 18 summarised | 6 human (4 randomized or controlled) of 9 summarised |
| Typical study doses |
|
|
Bracketed values are pending a sourced figure. Legal data reflects the regulatory events in our tracker.
Two routes to higher testosterone, with different track records
Enclomiphene has completed randomised phase III testing in men with secondary hypogonadism against testosterone gel. No such trial of kisspeptin is cited here.[8]
In the enclomiphene phase III studies, sperm concentration stayed in the normal range on enclomiphene but fell markedly in the testosterone gel group.[8]
The longest kisspeptin human study cited gave it subcutaneously to healthy men for 12 days, with gonadotropin and testosterone secretion sustained.[5]
In women with hypothalamic amenorrhoea, the response to kisspeptin was significantly reduced on the 14th injection day.[18]
Kisspeptins stimulate GnRH release and thus gonadotropin secretion.[17]
The two were not tested head to head in the studies cited. Anti-doping researchers flag kisspeptin's testosterone-raising effect as a potential misuse risk in sports.[2]
Practical differences from the trials and rules
Enclomiphene's trials used once-daily oral doses, while the kisspeptin studies cited used injection or infusion.[9]
In the phase II enclomiphene study, testosterone on the highest daily dose was not statistically different from transdermal testosterone (p = 0.23).[9]
The longest kisspeptin study used an intermittent schedule: 8 h on and 16 h off daily for 12 days.[5]
Kisspeptin is named in the testosterone-stimulating peptide group of WADA's list for male athletes.[1]
The cached WADA text names clomifene among anti-estrogenic substances; enclomiphene is not named in it.[1]
A case report describes new atrial flutter shortly after a man took 50 mg daily of enclomiphene in place of 25 mg daily. It is a single case, not a rate.[10]
Common questions
Is enclomiphene or kisspeptin better for testosterone?
Only enclomiphene has trials in men with low testosterone cited here. In one, FSH and LH rose and sperm counts were conserved. The kisspeptin studies cited are short physiology studies.[16]
Can kisspeptin be used long term?
The longest human data cited are 12 days in healthy men. A shorter study in women found the response reduced after repeated injections.[5]
Do enclomiphene and kisspeptin affect fertility?
Enclomiphene was reported to conserve sperm counts. Separately, a kisspeptin receptor agonist, MVT-602, is described as a candidate to trigger oocyte maturation in assisted reproduction.[4]
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2[Not Available].Biomedical chromatography : BMC · 2024PMID 38978171Accessed 2 Oct 2026
- 3Analysis and Characterization of Kisspeptin and Its Analogues in Serum and Urine Samples by Liquid Chromatography-High-Resolution Mass Spectrometry for Doping Control Purposes.Drug testing and analysis · 2026PMID 42057309Accessed 2 Oct 2026
- 4Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals.Fertility and sterility · 2024PMID 37925096Accessed 2 Oct 2026
- 5Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men.European journal of endocrinology · 2026PMID 42549827Accessed 2 Oct 2026
- 6Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.JAMA network open · 2022PMID 36287566Accessed 2 Oct 2026
- 7Hypothalamic-Pituitary-Testicular Axis Effects and Urinary Detection Following Clomiphene Administration in Males.The Journal of clinical endocrinology and metabolism · 2019PMID 30295816Accessed 2 Oct 2026
- 8Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.BJU international · 2016PMID 26496621Accessed 2 Oct 2026
- 9Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics.BJU international · 2013PMID 23875626Accessed 2 Oct 2026
- 10Newly Detected Atrial Flutter After Enclomiphene Dose Escalation in a Patient With Prior Mitral Valve Repair and Chronic Immune Thrombocytopenia: A Case Report.Cureus · 2026PMID 42741668Accessed 2 Oct 2026
- 11PubMed search: enclomiphene[tiab] OR enclomifene[tiab] OR "trans-clomiphene"[tiab] (98 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR meta-analysis[pt]) (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 13PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (hypogonadism[tiab] OR testosterone[tiab]) AND humans[mh] (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 14PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 15PubMed search: (enclomiphene[tiab] OR enclomifene[tiab] OR "trans-clomiphene"[tiab] OR Androxal[tiab]) AND ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab])PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 16Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.Fertility and sterility · 2014PMID 25044085Accessed 2 Oct 2026
- 17Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men.The Journal of clinical endocrinology and metabolism · 2011PMID 21632807Accessed 2 Oct 2026
- 18Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis.The Journal of clinical endocrinology and metabolism · 2009PMID 19820030Accessed 2 Oct 2026
- 19PubMed search: enclomiphene[tiab] OR enclomifene[tiab] OR Androxal[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
Found an error? Report a correction.